Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Optimizing empiric therapy for common infections

FY 2014-15

Summary
Background Antibiotics given within the first few hours of presentation have improved survival for serious infections. These infections are grouped into categories based on symptoms, clinical findings, typical microbiology, and anatomy to facilitate diagnosis and treatment decisions. Examples include pneumonia, skin & soft tissue infections, pyelonephritis, meningitis, osteomyelitis, and infective endocarditis. Randomized clinical trials (RCTs) are the gold standard for determining treatment efficacy. For each type of infection, multiple randomized trials and meta-analyses comparing antibiotics or antibiotic classes head-to-head have been performed. However, RCTs and meta-analyses are often underpowered to detect differences in patient-important outcomes, such as mortality. As such, the optimal empiric antibiotic regimen for most common infections often remains uncertain. Objective My thesis will use both direct and indirect evidence from randomized trials on antibiotic therapy to determine the relative effectiveness of antibiotics for common infections by using novel network meta-analysis (NMA) techniques. NMA uses both direct and indirect clinical trial evidence to estimate relative effects. Outcomes Patient-important outcomes will be used, including mortality. Clinical and microbiologic success will be defined differently for each infection as per literature standards, with the guidance from expert collaborators. Impact Optimal empiric antibiotic choices will be better defined, with the hope of harmonizing clinical practice and improving outcomes.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331604
Name
Siemieniuk Reed A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Optimizing empiric therapy for common infections
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotics; Bacterial Infections; Cystitis; Infection; Meta-Analysis; Mixed Treatment Comparisons; Network Meta-Analysis; Pneumonia; Pyelonephritis; Sepsis
Abstract
Background Antibiotics given within the first few hours of presentation have improved survival for serious infections. These infections are grouped into categories based on symptoms, clinical findings, typical microbiology, and anatomy to facilitate diagnosis and treatment decisions. Examples include pneumonia, skin & soft tissue infections, pyelonephritis, meningitis, osteomyelitis, and infective endocarditis. Randomized clinical trials (RCTs) are the gold standard for determining treatment efficacy. For each type of infection, multiple randomized trials and meta-analyses comparing antibiotics or antibiotic classes head-to-head have been performed. However, RCTs and meta-analyses are often underpowered to detect differences in patient-important outcomes, such as mortality. As such, the optimal empiric antibiotic regimen for most common infections often remains uncertain. Objective My thesis will use both direct and indirect evidence from randomized trials on antibiotic therapy to determine the relative effectiveness of antibiotics for common infections by using novel network meta-analysis (NMA) techniques. NMA uses both direct and indirect clinical trial evidence to estimate relative effects. Outcomes Patient-important outcomes will be used, including mortality. Clinical and microbiologic success will be defined differently for each infection as per literature standards, with the guidance from expert collaborators. Impact Optimal empiric antibiotic choices will be better defined, with the hope of harmonizing clinical practice and improving outcomes.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Siemieniuk, Reed A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~